NKGen Biotech Inc. Common... (NKGN)

NASDAQ: NKGN · Real-Time Price · USD

0.17

0.02 (13.33%)

At close: Apr 29, 2025, 3:56 PM

NKGen Biotech Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-82.95M	-26.75M	-23.27M
Depreciation & Amortization	1.2M	1.65M	1.24M
Stock-Based Compensation	4.13M	69K	93K
Other Working Capital	2.2M	59K	821K
Other Non-Cash Items	59.95M	2.27M	1.3M
Deferred Income Tax	-6.51M	177K	143K
Change in Working Capital	2.23M	30K	932K
Operating Cash Flow	-21.95M	-22.56M	-19.55M
Capital Expenditures	-48K	-163K	-459K
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-171.62M
Sales Maturities Of Investments	n/a	568.64K	n/a
Other Investing Acitivies	n/a	-568.64K	171.62M
Investing Cash Flow	-48K	-163K	-459K
Debt Repayment	26.21M	22.32M	20.1M
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	-5.72M	161K	n/a
Financial Cash Flow	22.16M	22.49M	20.16M
Net Cash Flow	159K	-234K	152K
Free Cash Flow	-22M	-22.72M	-20.01M